| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pathophysiology of Renal Disease and Progression |
Induced Epithelial-to-Mesenchymal Transition









* Division of Nephrology and Department of Internal Medicine,
Department of Biochemistry and Cell Biology, and
Department of Anatomy, Kyungpook National University School of Medicine, and
Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea
Address correspondence to: Dr. Yong-Lim Kim, Division of Nephrology and Department of Internal Medicine, Kyungpook National University Hospital, 50 Samduk-dong 2Ga, Jung-gu, Daegu 700-721, Korea. Phone: +82-53-420-5553; Fax: +82-53-423-7583; E-mail: ylkim{at}knu.ac.kr or Dr. Tae-Hwan Kwon, Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, 700-422 Korea. Phone: +82-53-420-4825, Fax: +82-53-422-1466; E-mail: thkwon{at}knu.ac.kr
Received for publication August 19, 2005. Accepted for publication February 3, 2007.
The inhibitory effects of recombinant human erythropoietin (rhEPO) were examined against (1) the progression of renal fibrosis in mice with complete unilateral ureteral obstruction and (2) the TGF-
1induced epithelial-to-mesenchymal transition (EMT) in MDCK cells. Unilateral ureteral obstruction was induced in BALB/c mice and rhEPO (100 or 1000 U/kg, intraperitoneally, every other day) or vehicle was administered from day 3 to day 14. Immunoblotting and immunohistochemistry revealed increased expressions of TGF-
1,
-smooth muscle actin (
-SMA), and fibronectin and decreased expression of E-cadherin in the obstructed kidneys. In contrast, rhEPO treatment significantly attenuated the upregulation of TGF-
1 and
-SMA and the downregulation of E-cadherin. MDCK cells were treated with TGF-
1 (5 ng/ml) for 48 h to induce EMT, and the cells were then co-treated with TGF-
1 and rhEPO for another 48 h. Increased expressions of
-SMA and vimentin and decreased expressions of zona occludens1 and E-cadherin were observed after TGF-
1 treatment, and these changes were markedly attenuated by rhEPO co-treatment. TGF-
1 increased phosphorylated Smad-2 expression in MDCK cells, which was decreased by rhEPO co-treatment. In conclusion, rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-
1induced EMT. It is suggested that the renoprotective effects of rhEPO could be mediated, at least partly, by inhibition of TGF-
1induced EMT.
This article has been cited by other articles:
![]() |
J.-H. Kie, M. H. Kapturczak, A. Traylor, A. Agarwal, and N. Hill-Kapturczak Heme Oxygenase-1 Deficiency Promotes Epithelial-Mesenchymal Transition and Renal Fibrosis J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1681 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673